ストックスクリーナーアプリを入手
1.37
2.14%
-0.03
アフターアワーズ：
1.36
-0.01
-0.73%
前日終値:
$1.40
開ける：
$1.38
24時間の取引高:
10,034
Relative Volume:
0.06
時価総額：
$10.04M
収益：
-
当期純損益:
$-7.50M
株価収益率:
-1.2365
EPS:
-1.108
ネットキャッシュフロー:
$-23.55M
1週間 パフォーマンス:
+15.13%
1か月 パフォーマンス:
-49.45%
6か月 パフォーマンス:
-18.45%
1年 パフォーマンス:
-60.69%
1日の値動き範囲:
$1.36
$1.3993
1週間の範囲:
$1.25
$1.5699
52週間の値動き範囲:
$1.051
$3.55
Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile
名前
Chemomab Therapeutics Ltd Adr
セクター
電話
972-77-331-0156
住所
KIRYAT ATIDIM, BUILDING 7, TEL AVIV
Compare CMMB vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CMMB
Chemomab Therapeutics Ltd Adr
|
1.37 | 15.83M | 0 | -7.50M | -23.55M | -1.108 |
VRTX
Vertex Pharmaceuticals Inc
|
505.64 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
196.48 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
742.12 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
928.44 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
200.87 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-13 | 開始されました | Maxim Group | Buy |
| 2024-05-06 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-12-19 | 再開されました | ROTH MKM | Buy |
Chemomab Therapeutics Ltd Adr (CMMB) 最新ニュース
Chemomab Therapeutics Updates Merger Agreement with Scipher Medicine Corporation - kalkinemedia.com
symbol__ Stock Quote Price and Forecast - CNN
Chemomab at H.C. Wainwright conference: merger sets ra push - Investing.com
HBM Healthcare Investments Reports 12.5% Stake in Chemomab Therapeutics (NASDAQ: CMMB), Initiates Pre-Funded Warrant Exercise - Kalkine Media
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update - Barchart.com
CMMB Stock Surges As Traders Target Biotech Momentum - timothysykes.com
Chemomab and Scipher Medicine to merge in $150M deal - Investing.com
CMMBChemomab Therapeutics Ltd ADR Volatility & Greeks - Finviz
11 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
Price to earnings forward of Chemomab Therapeutics Ltd. Sponsored ADR – MUN:2QV - TradingView
Enterprise value to EBIT forward of Chemomab Therapeutics Ltd. Sponsored ADR – MUN:2QV - TradingView
Chemomab Therapeutics Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:CMMB) - TradingView
2QV Forecast — Price Target — Prediction for 2027 - TradingView
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - Barchart.com
Top LosersStock ScreenerSnapshot - Finviz
Chemomab Therapeutics (CMMB) Institutional Ownership 2026 - marketbeat.com
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update - Barchart.com
Chemomab’s nebokitug shows disease-modifying potential in PSC trial - Investing.com
Zacks Investment ResearchGlobes - Globes - Israel Business News
SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study - Yahoo Finance
NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients - Yahoo Finance
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up - Yahoo Finance
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan - Yahoo Finance
RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - Yahoo Finance
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain - Yahoo Finance
CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza - Yahoo Finance
KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure - Yahoo Finance
Chemomab Therapeutics Ltd Share Price ADR Each Representing 80 Ord Shares SPON - Hargreaves Lansdown
Oppenheimer raises Chemomab stock price target to $25 on M&A potential - Investing.com
Jeff Jones Analyst Performance at Oppenheimer - MarketBeat
Chemomab Therapeutics (CMMB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail
NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study - Yahoo Finance
RCKT Stock Tanks on Patient Death in Danon Disease Study - Barchart.com
Chemomab Therapeutics LtdADR (CMMB) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Entero Therapeutics (ENTO) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Chemomab Therapeutics (CMMB) Stock Forecast and Price Target 2026 - MarketBeat
PMGC (ELAB) Short Interest & Short Float | Updated May 2026 - MarketBeat
What's going on in today's pre-market session - ChartMill
GRI Bio (GRI) Short Interest & Short Float | Updated Apr 2026 $GRI - MarketBeat
Which stocks are moving before the opening bell on Tuesday? - ChartMill
What is the current Price Target and Forecast for Chemomab Therapeutics (CMMB) - Zacks Investment Research
Want to Profit on the Downtrend? Downtrends, Explained. - MarketBeat
IO Biotech (IOBT) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Top movers in Tuesday's session - ChartMill
These stocks are moving in today's pre-market session - ChartMill
Chemomab Therapeutics (CMMB) 10K Form and Latest SEC Filings 2026 - MarketBeat
HCW Biologics (HCWB) Short Interest & Short Float | Updated May 2026 - MarketBeat
What date does Chemomab Therapeutics's (CMMB) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
These stocks are moving in today's after hours session - ChartMill
Chemomab Therapeutics Ltd Adr (CMMB) 財務データ
収益
当期純利益
現金流量
EPS
Chemomab Therapeutics Ltd Adr (CMMB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cohen Neil Harris | Director |
Aug 28 '26 |
Sale |
2.80 |
1,000 |
2,800 |
33,000 |
0.50%
0.57%
大文字化:
|
ボリューム (24 時間):